2
Announcements
Trials
Browse
Landscape
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Sponsor
Cancer Type
Classical hematology
1
CNS
1
Conditions
Brain Neoplasms
2306
Glioblastoma
2010
Glioma
1397
Central Nervous System Neoplasms
692
Astrocytoma
667
Neuroblastoma
647
Gliosarcoma
480
Neoplasms
405
Oligodendroglioma
404
Breast Neoplasms
327
Medulloblastoma
307
Carcinoma, Non-Small-Cell Lung
254
Meningioma
229
Recurrence
223
Sarcoma
214
Melanoma
206
Neoplasm Metastasis
202
Lung Neoplasms
198
Ependymoma
198
Neurofibromatosis 1
169
Lymphoma
161
Meningeal Carcinomatosis
138
Osteosarcoma
134
Ovarian Neoplasms
132
Wilms Tumor
123
Precursor Cell Lymphoblastic Leukemia-Lymphoma
123
Head and Neck Neoplasms
117
Lymphoma, Non-Hodgkin
116
Diffuse Intrinsic Pontine Glioma
113
Rhabdomyosarcoma
106
Interventions
ziprasidone
1
Zolpidem
1
Warfarin
1
Vecuronium Bromide
1
Vancomycin
1
Tranexamic Acid
1
Tobramycin
1
Spironolactone
1
Sevelamer
1
Rocuronium
1
Piperacillin, Tazobactam Drug Combination
1
Pentobarbital
1
Oxycodone
1
Nifedipine
1
Nafcillin
1
Molindone
1
Methylprednisolone
1
Lurasidone Hydrochloride
1
Labetalol
1
Haloperidol
1
Fosfomycin
1
Clozapine
1
Ciprofloxacin
1
Cidofovir
1
Cefepime
1
Bosentan
1
Aminocaproic Acid
1
Amikacin
1
Alfentanil
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Retinitis
×
CNS
×
Clear all
NCT01431326
2023-09-06
PTN_POPS
Duke University
Completed
3,520 enrolled